We are live on ! Find out more
Boston Partners

Boston Partners Portfolio holdings

AUM $113B
1-Year Est. Return 38.87%
This Fund
S&P 500
This Quarter Est. Return
-14.15%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$69.6B
AUM Growth
-$16.5B
Cap. Flow
-$3.3B
Cap. Flow %
-4.75%
Top 10 Hldgs %
17.71%
Holding
779
New
83
Increased
294
Reduced
313
Closed
76

Top Sells

Rank Stock Value
1
ANDV
Andeavor
ANDV
+$1.05B
2
MRK icon
Merck
MRK
+$702M
3
BAC icon
Bank of America
BAC
+$542M
4
ORCL icon
Oracle
ORCL
+$528M
5
STLD icon
Steel Dynamics
STLD
+$499M

Sector Composition

Rank Sector Weight
1 Financials 26.74%
2 Healthcare 14.95%
3 Industrials 13.38%
4 Technology 12.24%
5 Energy 6.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTO
501
CTO Realty Growth
CTO
$809M
$2.66M ﹤0.01%
186,779
-37,945
-17% -$594K
HOPE icon
502
Hope Bancorp
HOPE
$1.78B
$2.65M ﹤0.01%
223,690
+4,542
+2% +$65K
CNBKA
503
DELISTED
Century Bancorp Inc/Mass
CNBKA
$2.65M ﹤0.01%
39,170
-8,530
-18% -$657K
STMP
504
DELISTED
Stamps.com, Inc.
STMP
$2.64M ﹤0.01%
+16,983
New +$3.02M
GGB icon
505
Gerdau
GGB
$9.01B
$2.63M ﹤0.01%
882,000
LQDT icon
506
Liquidity Services
LQDT
$1.3B
$2.62M ﹤0.01%
424,846
-69,115
-14% -$427K
EEFT icon
507
Euronet Worldwide
EEFT
$2.62B
$2.62M ﹤0.01%
25,584
-9,682
-27% -$1.07M
HOLI
508
DELISTED
Hollsys Automation Technologies INTERNATIONAL, LTD. COMMON (British Virgin Island)
HOLI
$2.58M ﹤0.01%
+147,120
New +$2.8M
EPD icon
509
Enterprise Products Partners
EPD
$84.3B
$2.56M ﹤0.01%
103,963
-64,832
-38% -$1.74M
MSTR icon
510
Strategy Inc
MSTR
$50.6B
$2.53M ﹤0.01%
197,700
+82,700
+72% +$1.05M
FLR icon
511
Fluor
FLR
$7.12B
$2.51M ﹤0.01%
77,853
-1,116,811
-93% -$48.2M
DLB icon
512
Dolby
DLB
$5.76B
$2.5M ﹤0.01%
40,404
-20,552
-34% -$1.38M
YPF icon
513
YPF Sociedad Anonima ADS
YPF
$19.7B
$2.46M ﹤0.01%
184,110
+50,014
+37% +$735K
XHR
514
Xenia Hotels & Resorts
XHR
$1.8B
$2.45M ﹤0.01%
+142,640
New +$2.9M
CTXS
515
DELISTED
Citrix Systems Inc
CTXS
$2.43M ﹤0.01%
23,717
-8,397
-26% -$887K
NBN icon
516
Northeast Bank
NBN
$1.11B
$2.4M ﹤0.01%
143,613
-30,287
-17% -$585K
MXIM
517
DELISTED
Maxim Integrated Products
MXIM
$2.4M ﹤0.01%
+47,176
New +$2.46M
FFIC
518
DELISTED
Flushing Financial
FFIC
$2.36M ﹤0.01%
109,535
+2,150
+2% +$48K
CPAY icon
519
Corpay
CPAY
$26.8B
$2.36M ﹤0.01%
+12,697
New +$2.48M
GAP
520
The Gap Inc
GAP
$8.45B
$2.35M ﹤0.01%
+91,328
New +$2.44M
ABCB icon
521
Ameris Bancorp
ABCB
$5.74B
$2.32M ﹤0.01%
73,120
-26,960
-27% -$1.1M
PWR icon
522
Quanta Services
PWR
$90.6B
$2.32M ﹤0.01%
76,946
+484
+0.6% +$15.6K
TGNA
523
DELISTED
TEGNA Inc
TGNA
$2.3M ﹤0.01%
211,676
+20,304
+11% +$245K
AROC icon
524
Archrock
AROC
$5.48B
$2.3M ﹤0.01%
307,022
-145,610
-32% -$1.48M
MPLX icon
525
MPLX
MPLX
$60.1B
$2.28M ﹤0.01%
75,275
-55,420
-42% -$1.85M

Similar funds

Boston Partners's Q4 2018 Portfolio in Review

As of Q4 2018, Boston Partners held 779 positions worth $69.6B, down 19% from $86.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Partners withdrew a net $3.3B in Q4 2018, closing 76 positions and reducing 313 holdings. Its most notable exit was Andeavor, an estimated $1.05B position sold in full.

By sector, the portfolio is most concentrated in Financials at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Boston Partners opened a new position in Procter & Gamble worth $775M.

  • Boston Partners's largest Q4 2018 buy was Procter & Gamble: 8,428,522 shares worth $775M.
  • Boston Partners added most to Marathon Petroleum in Q4 2018, an estimated $374M increase.
  • Boston Partners's biggest Q4 2018 reduction was Merck, cutting an estimated $702M.
  • Boston Partners fully exited Andeavor in Q4 2018, selling an estimated $1.05B.
  • Boston Partners's ten largest holdings make up 18% of its $69.6B portfolio in Q4 2018.
  • Boston Partners opened 83 new positions and closed 76 in Q4 2018.
  • Boston Partners's portfolio value fell 19% quarter-over-quarter to $69.6B.

Based on Boston Partners's 13F filing for Q4 2018, filed 7 Feb 2019.